Unruptured cerebral aneurysms of sizes and locations that require attention may be frequently missed in routine clinical care, but a machine learning algorithm could minimize missed care opportunities, according to a new study from UTHealth Houston.
The new University of Chicago Healthy Aging & Alzheimer's Research Care (HAARC) Center will focus on building deep multidisciplinary expertise and bridging the gap between scientific disciplines to accelerate breakthroughs in cognitive resilience.
Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals.
Using gene therapy to treat many neurologic diseases, such as Alzheimer’s and Parkinson’s, has long been a long-sought goal of researchers, but the blood-brain barrier has proven very difficult to cross.
An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.
Focused ultrasound technology holds promise for treating millions suffering from addiction.
Scientists from Immanuel Kant Baltic Federal University and Institute of Higher Nervous Activity and Neurophysiology of RAS have described in detail disturbances in rhythm of brain that are observed among patients with Rett syndrome – severe genetical disorder, that leads to decline of mental abilities, memory and ability to control movements.
Newly approved anti-amyloid therapies that slow Alzheimer’s disease progression offer new hope for people with the disorder.
The Richmond, Virginia-based Red Gates Foundation recently committed $50 million to the Fralin Biomedical Research Institute at VTC to accelerate health sciences research at Virginia Tech. The gift is among the largest ever made to the university.
Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a significantly increased risk of ischemic stroke in a diverse group of U.S. adults, according to new research being presented at the 148th Annual Meeting of the American Neurological Association (ANA). Suffering more than one head injury further increased the risk.
Even the best treatment approaches for Parkinson’s disease are inadequate if they do not address patients’ feelings of social rejection, isolation, loneliness and other psychosocial effects of stigma, according to a report from experts specializing in Parkinson’s and other movement disorders.
The zebrafish brain, though simpler than its human counterpart, is a complex network of neurons that engage in a ceaseless dance of electrical activity. What if this neural ballet could reveal the secrets of how brains, including our own, control movement?
Breakthrough platform opens new possibilities for treating neurological diseases, including paralysis.
Nearly 100 drugs for multiple sclerosis (MS), blood cancers, rheumatoid arthritis and other diseases may cause Progressive Multifocal Leukoencephalopathy (PML), a rare but often-fatal condition. A simple genetic test can determine who has a 10-fold higher risk for the condition so they can discuss safer treatment options with their physicians. The largest study to date on drugs that increase the risk for PML and the genetic link to the disease is being presented at the 148th Annual Meeting of the American Neurological Association (ANA).
Neurological disorders – including autism spectrum disorder (ASD), Alzheimer’s disease and Parkinson’s disease – cause sleep disturbances that make life extra challenging for people with those conditions. Improving sleep not only helps improve their quality of life, evidence is mounting that good sleep is vital for a healthy brain and may reduce the risk of some neurological disorders, according to neurologists speaking at the Presidential Symposium – Exploring Sleep Disturbances in CNS Disorders plenary session at the 148th Annual Meeting of the American Neurological Association (ANA).
Credentialed press representatives are invited to attend the Congress of Neurological Surgeons 2023 Annual Meeting in Washington, DC.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Colin Franz as one of the 2023 Scientific Impact Award.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Monika Krzesniak-Swinarska as the 2023 Ernest Johnson Outstanding Educator Award recipient for her unwavering dedication to education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
Rochester, Minn. (Sept. 09, 2023)- The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. David R. Cornblath as the 2023 Distinguished Researcher Award recipient for his contributions to the study of peripheral neuropathies and his extensive research in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Brooke Eby as the 2023 Public Recognition Award recipient for her remarkable commitment to raising awareness about muscle and nerve disorders, specifically amyotrophic lateral sclerosis (ALS).
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Teresa Spiegelberg, CNCT, R.NCS.T., R.EEG.T, BS, as the inaugural Outstanding Service Award recipient for her dedicated service to patients, medical education, and AANEM.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Amanda C. Peltier as the 2023 Jun Kimura Outstanding Educator Award recipient for her numerous contributions and dedication to advancing medical education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
Rochester, Minn. (Sept. 09, 2023)- The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Bassam A. Bassam as the 2023 Distinguished Physician Award recipient for his exceptional contributions to patient care, research, and education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.
A three-year, $3.4 million grant to investigate how Alzheimer’s disease is connected to multiple chronic diseases has been awarded to UTHealth Houston researchers by the National Institute on Aging, part of the National Institutes of Health.
District of Columbia Mayor Muriel Bowser Proclaims Sept. 7-13, Pathway to Neurosurgery Week.
The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.
SMU biology professor Zhihao Wu has received a $1.8 million, 5-year Maximizing Investigators' Research Award (MIRA) from the National Institutes of Health to determine if different quality control pathways in our bodies might be working together to repair damaged components in cells.
Researchers have received a U.S. patent for a novel method to identify therapeutic agents to treat addiction. The invention, related to the fields of pharmacology, medicine, neurology and psychiatry, targets the protein MBLAC1, which the Blakely lab identified as the mammalian form of a gene the group first identified in worms as a modifier of signaling by the neurotransmitter dopamine.
Russian neurobiologists have created computer software that can automatically analyze and classify the shape of dendritic spines. The program is based on machine learning techniques.
Electrodes that collect research data while locating seizure origins may spur better treatment for many brain conditions.
A study of twins shows that having a concussion early in life is tied to having lower scores on tests of thinking and memory skills decades later as well as having more rapid decline in those scores than twins who did not have a concussion, or traumatic brain injury (TBI). The study is published in the September 6, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
An international study led by the Coma Science Group of the University of Liège (BE) and involving more than ten institutions has tested transcranial direct current stimulation (tDCS) on a large number of patients suffering from consciousness disorders following severe brain injury.
When an immunocompromised person’s system begins to recover and produce more white blood cells, it’s usually a good thing – unless they develop a potentially deadly inflammatory condition.
Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence of brain tumors by measuring abnormal genetic material shed by tumors and circulating in cerebrospinal fluid (CSF). A description of the work was published Aug. 15 in the journal Cell Reports Medicine.
A team of researchers led by Stony Brook University scientists believe they have a new understanding of cognitive adaptability and the role of adult neurogenesis. Their work and findings are highlighted in two recent papers, one in the Journal of Neuroscience, and one in Frontiers in Neuroscience.
A Florida State University researcher has received a five-year, $1.86 million grant from the National Institutes of Health to study how a little-understood part of the brain affects our sense of smell.
Cedars-Sinai Neurosurgery experts who treat the most aggressive form of brain cancer and specialize in leading-edge spine surgery techniques will present research and discuss pioneering therapies at the Congress of Neurological Surgeons 2023 Annual Meeting Sept. 9-13 in Washington, D.C.
Thanks to a $24.5 million grant from the National Institutes of Health National Center for Advancing Translational Sciences (NCATS), Johns Hopkins Medicine today announced plans to continue with a trial innovation center (TIC) that will promote improvements in the efficiency and quality of National Institutes of Health-funded clinical trials across multiple disease areas.
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the brain from other parts of the body respond to immunotherapy while glioblastoma, an aggressive cancer that originates in the brain, does not.
Neuroscience researchers at Wayne State University published a review article that confirms the usefulness of neurofilament light (NfL) blood levels to predict the likelihood and rate of progression of neurodegeneration in Alzheimer’s disease.
Announcement of contents of the September 2023 issue of Neurosurgical Focus
A new study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.
People who have had a stroke called an intracerebral hemorrhage who take cholesterol-lowering drugs called statins may have a lower risk of having another stroke, especially ischemic stroke, compared to people who also had an intracerebral hemorrhage but were not taking statins, according to a new study published in the August 30, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Disrupted connections between memory and appetite regulating brain circuits are directly proportional to BMI, notably in patients who suffer from disordered or overeating that can lead to obesity, such as binge eating disorder, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
UC Davis MIND Institute Director Leonard Abbeduto has co-authored a paper in the American Journal on Intellectual and Developmental Disabilities that calls for a paradigm shift in disability research.
An Indiana University School of Medicine statewide project in collaboration with Indiana University Health was recently funded to support people living with dementia as well as their family care partners find more support and resources, thanks to a new $686,000 grant from the National Institute on Aging IMPACT Collaboratory.
When customers began complaining that their vehicles with driver-assistance technologies were “phantom braking” or slamming on the brakes without any visible obstacles present, researchers at Michigan State University wanted to learn more about this phenomenon — why it happens and how to stop it.
The American Physiological Society (APS) is pleased to announce our translational neuroscience webinar series, “Neurophysiology: Exploring Basic and Clinical Consequences,” hosted in partnership with the Society for Neuroscience, Federation of European Neuroscience Societies, American Autonomic Society and InsideScientific.
Patients whose brains appear older on scans than their chronological age showed less improvement on sertraline, a first-line drug treatment for major depressive disorder (MDD), researchers from UT Southwestern Medical Center reported.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right